Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan L Block

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Vaccine|July 30, 2008
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of ageStan L Block, Ram Yogev, Frederick G Hayden, et al.
The Pediatric Infectious Disease Journal|October 20, 2015
Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label TrialStan L Block, Julie Shepard, Hartley Garfield, et al.
The Pediatric Infectious Disease Journal|September 28, 2002
Pneumococcal serotypes from acute otitis media in rural KentuckyStan L Block, James Hedrick, Christopher J Harrison, et al.
The Pediatric Infectious Disease Journal|September 14, 2004
Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis mediaStan L Block, James Hedrick, Christopher J Harrison, et al.
Vaccine|March 7, 2015
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccinationStan L Block, Shane Christensen, Bikash Verma, et al.
The Pediatric Infectious Disease Journal|April 7, 2012
Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old childrenStan L Block, Guillermo M Ruiz-Palacios, M Lourdes Guerrero, et al.
Expert Review of Vaccines|November 16, 2012
Quadrivalent Ann Arbor strain live-attenuated influenza vaccineSeth L Toback, Myron J Levin, Stan L Block, et al.
Clinical Pediatrics|June 5, 2010
Post hoc analysis: early changes in ADHD-RS items predict longer term response to atomoxetine in pediatric patientsStan L Block, David Williams, Craig L Donnelly, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in childrenStan L Block, Judith Falloon, Jeffrey A Hirschfield, et al.
Journal of Patient-Reported Outcomes|May 15, 2018
Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trialsSandy Lewis, Carla DeMuro, Stan L Block, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Vaccine|July 30, 2008
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of ageStan L Block, Ram Yogev, Frederick G Hayden, et al.
The Pediatric Infectious Disease Journal|October 20, 2015
Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label TrialStan L Block, Julie Shepard, Hartley Garfield, et al.
The Pediatric Infectious Disease Journal|September 28, 2002
Pneumococcal serotypes from acute otitis media in rural KentuckyStan L Block, James Hedrick, Christopher J Harrison, et al.
The Pediatric Infectious Disease Journal|September 14, 2004
Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis mediaStan L Block, James Hedrick, Christopher J Harrison, et al.
Vaccine|March 7, 2015
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccinationStan L Block, Shane Christensen, Bikash Verma, et al.
The Pediatric Infectious Disease Journal|April 7, 2012
Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old childrenStan L Block, Guillermo M Ruiz-Palacios, M Lourdes Guerrero, et al.
Expert Review of Vaccines|November 16, 2012
Quadrivalent Ann Arbor strain live-attenuated influenza vaccineSeth L Toback, Myron J Levin, Stan L Block, et al.
Clinical Pediatrics|June 5, 2010
Post hoc analysis: early changes in ADHD-RS items predict longer term response to atomoxetine in pediatric patientsStan L Block, David Williams, Craig L Donnelly, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in childrenStan L Block, Judith Falloon, Jeffrey A Hirschfield, et al.
Journal of Patient-Reported Outcomes|May 15, 2018
Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trialsSandy Lewis, Carla DeMuro, Stan L Block, et al.
Pageof 12